Navigation Links
Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
Date:1/9/2008

SEATTLE, Jan. 9 /PRNewswire/ -- Omeros Corporation announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Omeros. Deutsche Bank Securities Inc. will be acting as the sole book-running manager. Pacific Growth Equities, LLC will be acting as the co- lead manager, and Leerink Swan LLC and Needham & Company, LLC will be acting as co-managers. The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus may be obtained from Deutsche Bank Securities Inc. by mail, Attn: Prospectus Department, 100 Plaza One, Floor 2, Jersey City, NJ 07311, by telephone at (800)-503-4611 or by email: prospectusrequest@list.db.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Omeros Corporation

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urol
'/>"/>

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
2. Pharmos Corporation Completes Initial Closing of Private Placement
3. Pharmos Corporation Announces Board and Management Changes
4. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
5. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
6. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
7. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
10. FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products
11. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 ReliantHeart, Inc., an innovative ... a supplier of precision transit-time flow measurement solutions, are ... improve the efficiency of the HeartAssist5® Left ... to experience greater mobility and peace of mind. ... flow board, will draw 1/6th of the power required ...
(Date:3/26/2015)... Ale Gicqueau, Founder and President of Clinovo, will co-present ... Technology, on “ Conducting Postmarket Registries - Rationale and ... and Exhibition on April 25th through April 28th in ... presentation, Ale Gicqueau and Victor Chen will discuss the ... requirements and resources to conduct the registry, as well ...
(Date:3/25/2015)... the most attractive in the emerging European region, mainly ... and increasing government investment in healthcare, according to a ... set to grow at twice the pace of the ... reaching an approximate market value of $43-60 billion by ... Cross provides total healthcare solutions that address the evolving ...
(Date:3/25/2015)... , March 25, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... as a result of recent discussions with certain shareholders ... of the Company, after dealing with certain matters including ... meeting of shareholders on March 26, 2015 (the "Meeting") ... election of directors will take place when the Meeting ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 2Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5
... CORPORATE STRATEGY, RANCHO CORDOVA, Calif., Sept. 12 ,ThermoGenesis ... enabling,technologies for stem cell therapy, today reported results for ... for the quarter ended June 30, 2007 were $3,520,000 ... fiscal 2006. Revenues,related to the Company,s stem cell therapy ...
... 12 Sigma-Aldrich (Nasdaq:,SIAL) has announced its intent ... District,Park (WND) located northwest of Shanghai, China, for ... memorandum of understanding,with the WND authorities. The ... Sigma-Aldrich expects to,initially invest $25 million to acquire ...
... have found that the body,s innate ability to adapt ... effective and less costly artificial respirators. The new approach ... paralysis currently necessary for some patients on mechanical ventilation. ... to recurring stimuli, is the focus of work to ...
Cached Biology Technology:ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 2ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 3ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 4ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 5ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 6ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 7Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth 2Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth 3MIT: Leveraging learning for artificial respiration 2
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided ...
(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... DNA sequence of the mouse genome that may play ... gene expression. The research, led by Emory University scientists ... be published in the Aug. 22 Advance Online publication ... the basic code of chemical bases that comprise the ...
... of the American Chemical Society (ACS) News Service Weekly ... from scientific presentations scheduled for the ACS 234th national ... ACS 36 major peer-reviewed journals and Chemical & Engineering ... , ACS NEWS SERVICE , Weekly ...
... When your body cranks up the heat, its a ... help fight off the infection. But turning up the ... in 25 infants or small children, high fever can ... generally harmless, a prolonged fever resulting from infection or ...
Cached Biology News:Scientists find clue to mechanisms of gene signaling and regulation 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 3American Chemical Society's Weekly PressPac -- Aug. 15, 2007 4American Chemical Society's Weekly PressPac -- Aug. 15, 2007 5American Chemical Society's Weekly PressPac -- Aug. 15, 2007 6American Chemical Society's Weekly PressPac -- Aug. 15, 2007 7American Chemical Society's Weekly PressPac -- Aug. 15, 2007 8American Chemical Society's Weekly PressPac -- Aug. 15, 2007 9American Chemical Society's Weekly PressPac -- Aug. 15, 2007 10American Chemical Society's Weekly PressPac -- Aug. 15, 2007 11American Chemical Society's Weekly PressPac -- Aug. 15, 2007 12American Chemical Society's Weekly PressPac -- Aug. 15, 2007 13Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures 2
... 2.0 network client/server version of Freezerworks Unlimited includes ... high-volume labs and facilitates the sharing of freezers ... sample information. ... PPC 601); 13 in monitor with 256 colors; ...
Applications: Immunohistochemistry, ISH, FISH, CISH....
... TempliPhi 500 Amplification Kit, 500 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
... Microplate Rack inserts fit ... Rack, and allow you to ... capacity, shake deepwell format plates ... many plates from the shaker ...
Biology Products: